Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth

Dopamine receptor D3 is related to prognosis in human hepatocellular carcinoma and inhibits tumor growth

Abstract Background Dopamine receptors have been reported to play important roles in cancer progression. However, the role of dopamine receptor D3 (DRD3) in hepatocellular carcinoma (HCC) remains unclear. Methods The expression of DRD3 was detected by immunohistochemistry and real-time qPCR. The pro...

Full description

Bibliographic Details
Main Authors: Yan Yan, Yonghua Chen, Jiahao Pan, Wei Xing, Qiang Li, Yan Wang, Liba Gei, Yunfei Yuan, Jingdun Xie, Weian Zeng, Dongtai Chen
Format: Article
Language:English
Published: BMC 2022-12-01
Series:BMC Cancer
Subjects:
Dopamine receptor D3
Hepatocellular carcinoma
Prognosis
Target therapy
ERK pathway
Online Access:https://doi.org/10.1186/s12885-022-10368-y

Internet

https://doi.org/10.1186/s12885-022-10368-y

Similar Items